Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 977 of 5804
-
New hope for rare blood cancers: pacritinib trial opens for teens and adults
Disease control Recruiting nowBackground: Myelodysplastic syndrome (MDS) and myelodysplastic/myeloproliferative neoplasm (MDS/MPN) are blood disorders that can cause serious complications in children and adults. MDS and MDS/MPN can also progress to acute myeloid leukemia. Treatments for these disorders are r…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New scan could spot hidden scarring in heart and lungs before It's too late
Diagnosis Recruiting nowBackground: Injury or diseases of the heart and lung can sometimes cause scar tissue (fibrosis) to build up in those organs. Current imaging scans can see this scar tissue once it has formed, but researchers want to find a way to detect the fibrosis in its earliest stages, while…
Phase: PHASE3 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Diagnosis
Last updated Jul 26, 2026 00:00 UTC
-
New drug cocktail targets Hard-to-Treat myeloma
Disease control TerminatedBackground: Multiple myeloma (MM) is a type of blood cancer that affects a person s immunity. MM returns after treatment (relapse) in almost all people; MM may also not respond to initial treatment (refractory). Many people with relapsed refractory MM (RRMM) also have changes in…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Blood flow cuffs or instrument massage: which boosts ACL recovery best?
Disease control Recruiting nowThis randomized clinical trial aims to compare the effects of Blood Flow Restriction Training (BFR) and Instrument-Assisted Soft Tissue Mobilization (IASTM) on pain, quadriceps muscle strength, knee range of motion (ROM), and kinesiophobia in patients following anterior cruciate …
Phase: NA • Sponsor: Lahore University of Biological and Applied Sciences • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New malaria pill shows promise in early trial
Disease control Not yet recruitingThe study will evaluate the safety and efficacy of a new antimalarial drug GSK3772701 (a pyrrolidinamide), using different doses and treatment durations, in adult participants with uncomplicated Plasmodium (P.) falciparum malaria.
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New lupus drug tested in kids for first time
Disease control Not yet recruitingThe purpose of this study is to characterize the pharmacokinetics (PK), pharmacodynamics (PD), and safety of subcutaneous (SC) anifrolumab in pediatric participants with moderate to severe systemic lupus erythematosus (SLE) while on background standard of care (SoC) therapy.
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
A squirt of steroid during surgery may stop voice loss
Prevention Not yet recruitingThe goal of this clinical trial is to evaluate whether intraoperative spraying of dexamethasone onto the abdominal vagal nerve-rich areas can prevent postoperative hoarseness in patients undergoing elective upper abdominal surgery. The main questions it aims to answer are: * Doe…
Phase: NA • Sponsor: Fujian Medical University Union Hospital • Aim: Prevention
Last updated Jul 25, 2026 00:00 UTC
-
Shake it off? Whole-Body vibration may help heal wrist fractures
Disease control Not yet recruitingThis study is a randomized controlled clinical trial designed to evaluate the effects of whole body vibration (WBV) added to conventional rehabilitation on functional and sensorimotor recovery in patients with conservatively treated distal radius fractures. Following immobilizati…
Phase: NA • Sponsor: Istanbul University • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could a breathing app and exercise team up to beat high blood pressure?
Disease control Not yet recruitingHypertension is a major risk factor for cardiovascular disease and is associated with reduced functional capacity and impaired quality of life. Non-pharmacological interventions, including aerobic exercise and paced breathing, may improve blood pressure control by enhancing cardi…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Experimental combo aims to tackle Treatment-Resistant cancers
Disease control Not yet recruitingThe purpose of this first-in-human study is to evaluate the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of TLN-499 in combination with venetoclax in participants with relapsed/refractory solid tumors.
Phase: PHASE1 • Sponsor: Treeline Biosciences, Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New speech therapy approach may help children with cleft palate speak more clearly
Disease control ENROLLING_BY_INVITATIONCleft Palate ± Lip (CP±L) is one of the most well-known congenital anomalies worldwide. Children and adolescences with CP±L are at high risk of developing speech and communication difficulties due to a range of cleft-related etiologies. Even with timely or early repair of the pal…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Could virtual reality help patients recover faster from cell therapy?
Symptom relief Not yet recruitingCell therapy (CT), including hematopoietic stem cell transplantation (HSCT) and advanced CAR T-cell therapies, is used for the treatment of oncohematological and other diseases. HSCT is associated with treatment-related toxicities, including fatigue, muscle weakness, and reduced …
Phase: NA • Sponsor: Fundacin Biomedica Galicia Sur • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Hope for kids with scarred lungs: new drug trial launches
Disease control Recruiting nowThis study is open to children and adolescents aged 2 to 17 years with interstitial lung disease (ILD). Nerandomilast has just been approved in some countries to help adults with a lung condition called idiopathic pulmonary fibrosis. The purpose of this study is to understand how…
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New shorter radiation regimen aims to improve sarcoma treatment
Disease control Recruiting nowThis trial aims to assess the long-term efficacy of moderately hypofractionated neoadjuvant radiotherapy for soft tissue sarcoma in the limbs or trunk wall. The primary outcome is local disease control, assessed by the cumulative incidence of progression/recurrence. After inform…
Phase: PHASE2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a new Non-Opioid drug replace opioids for Post-Surgery pain?
Symptom relief ENROLLING_BY_INVITATIONThe purpose of this study is to find out how well suzetrigine, a newly FDA-approved non-opioid pain medication, works to relieve pain after thumb basal joint replacement surgery. The researchers believe that suzetrigine may provide effective pain relief during recovery without th…
Sponsor: Rothman Institute Orthopaedics • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Sleep hormone melatonin put to the test against lupus fatigue and inflammation
Symptom relief Not yet recruitingThe aim of the current study is to evaluate the effect of melatonin administration on circulating levels of inflammatory mediators, oxidative stress, sleep quality, fatigue and quality of life in patients with SLE. To the best of our knowledge, this is the first randomized-contro…
Phase: PHASE2, PHASE3 • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Experimental shot aims to clear stubborn HPV infection in the anal region
Disease control Recruiting nowThis is an open-label, single-center, investigator-initiated exploratory trial evaluating NWRD09 in 10 participants with persistent HPV16 infection in the anal region.
Phase: PHASE1 • Sponsor: Newish Biotech (Wuxi) Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Could a simple screening strategy uncover hidden TB in COPD patients?
Knowledge-focused Not yet recruitingThe goal of this trial is to evaluate the effectiveness of an active case-finding (ACF) strategy for detecting pulmonary tuberculosis (PTB) among patients with chronic obstructive pulmonary disease (COPD) in primary care settings in Henan Province, China. It will also assess the …
Phase: NA • Sponsor: Henan Provincial People's Hospital • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Can a higher dose slow lung damage in Alpha-1 patients?
Disease control Not yet recruitingThis is a multicenter, parallel-group, double-blind, randomized phase 4 study designed to identify the optimal dose of CE1226 (2 active doses) to slow disease progression as assessed by reduced rates of annual lung density decline in alpha-1 antitrypsin (AAT) deficient participan…
Phase: PHASE4 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Could a tubeless anesthesia technique protect the brain during lung surgery?
Knowledge-focused Not yet recruitingThis project conducts a prospective cohort study. By using multiple questionnaire survey methods such as the Pittsburgh Sleep Quality Index (PSQI) electronic wristband, QOR15, Pain Catastrophizing Scale (PCS), European Five-Dimensional Health Scale (EQ-5D), Revised American Pain …
Sponsor: Guangzhou Medical University • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC